compounded liraglutide
Selected indexed studies
- GLP-1 agonists: A review for emergency clinicians. (Am J Emerg Med, 2024) [PMID:38241775]
- Safety analysis of compounded GLP-1 receptor agonists: a pharmacovigilance study using the FDA adverse event reporting system. (Expert Opin Drug Saf, 2026) [PMID:40285721]
- Impact of Manufacturing Process and Compounding on Properties and Quality of Follow-On GLP-1 Polypeptide Drugs. (Pharm Res, 2024) [PMID:39379664]
_Worker-drafted node — pending editorial review._
Connections
compounded liraglutide is a side effect of
Sources
- GLP-1 agonists: A review for emergency clinicians. (2024) pubmed
- Safety analysis of compounded GLP-1 receptor agonists: a pharmacovigilance study using the FDA adverse event reporting system. (2026) pubmed
- Impact of Manufacturing Process and Compounding on Properties and Quality of Follow-On GLP-1 Polypeptide Drugs. (2024) pubmed
- Compounded glucagon-like peptide-1 receptor agonists for weight loss: the direct-to-consumer market in Colorado. (2025) pubmed
- Drugs for type 2 diabetes. (2019) pubmed
- Pharmacotherapy of obesity - state of the art. (2018) pubmed
- Challenges in the management of obesity. (2026) pubmed
- Pharmacotherapy for obesity in individuals with type 2 diabetes. (2018) pubmed
- Liraglutide-loaded poly(lactic-co-glycolic acid) microspheres: Preparation and in vivo evaluation. (2016) pubmed
- In response: Considerations regarding compounding pharmacies and GLP-1 agonists. (2024) pubmed